4,8-Dichloroquinazoline, 95.0%, 25g

(S)-1-(4-(Methylsulfonyl)phenyl)ethanamine, 95.0%, 250mg

(S)-Methyl 2-amino-2-phenylacetate hydrochloride, 95.0%, 100g

N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-(tert-butylthio)-L-cysteine, 97%, 10g

1-(6-Nitropyridin-3-yl)piperazine, 95.0%, 1g

5-Fluoro-4-hydroxyquinazoline, 95.0%, 1g

N-(4-pyridinylmethyl)-2-butanamine hydrochloride, 95.0%, 1g

2,2,2-Trifluoro-1,1-dimethyl-ethylamine hydrochloride, 95.0%, 25g

tert-Butyl (5-(2-hydroxyethyl)pyridin-2-yl)carbamate, 95.0%, 250mg

Ethyl 3-(N-butyl-2-methylbenzamido)propanoate, 97%, 100mg

2-Nitrobenzaldehyde, min. 98%, for synthesis, 25 g, plastic packaging.

2-Bromo-6-fluoro-4-methylphenylisothiocyanate, 95.0%, 1g

2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 97.0%, 500g